Clinical Trial Update: Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study evaluating adjuvant capecitabine after surgical resection of pancreatic adenocarcinoma; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Pancreatic Adenocarcinoma | Phase 4 | Status: COMPLETED